RCS (RCS) Stock Price & Analysis
RCS (RCS) fell 0.19% to USD 5.15 as of July 26, 2026 at 22:56 UTC, according to Nexqual real-time market data.
RCS last closed at USD 5.16; the session ranged USD 5.15–5.35 on volume of 132,789 shares. Market capitalization is $243.20M, with a 52-week range of USD 5.09–8 (NYQ). Source: Nexqual, July 26, 2026 at 22:56 UTC.
Key Statistics (as of July 26, 2026 at 22:56 UTC)
| Price | USD 5.15 |
|---|---|
| Change | ▼ 0.19% (down) |
| Previous Close | USD 5.16 |
| Open | USD 5.14 |
| Day Range | USD 5.15 – 5.35 |
| 52-Week Range | USD 5.09 – 8 |
| Volume | 132,789 shares |
| Market Cap | $243.20M |
| Exchange | NYQ |
Technical Analysis (RCS)
Nexqual's technical model rates RCS "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 26, 2026 at 22:56 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 31.21 (neutral) |
| vs SMA50 | Below (USD 5.39) |
| MACD | -0.07 (negative) |
Analyst Ratings (RCS)
Wall Street analysts rate RCS "None", per Nexqual as of July 26, 2026 at 22:56 UTC.
| Consensus Rating | None |
|---|
Earnings (RCS)
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Financials & Fundamentals (RCS)
| Total Revenue | $28.89M |
|---|---|
| Revenue Growth (YoY) | -4.70% |
| Gross Margin | +100.00% |
| Operating Margin | +92.48% |
| Profit Margin | +121.83% |
| ROE | +16.50% |
| Debt / Equity | 39.87 |
| Current Ratio | 0.59 |
| Total Cash | $1.69M |
| Total Debt | $88.26M |
| Free Cash Flow | $11.49M |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Financial Health Score (RCS)
Nexqual rates RCS's overall financial health "Mixed" across five dimensions, as of July 26, 2026 at 22:56 UTC.
| Growth | Weak — Revenue -5% YoY (latest Q), declining |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $2M cash vs $88M debt |
| Cash Flow | Strong — FCF $11M, 40% margin |
| Efficiency | Solid — ROE 17%, ROA 1.7% |
Ownership (RCS)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +10.52% |
| Shares Outstanding | 47.22M |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Major Backers & Investors (RCS)
Notable institutional backers of RCS include Cambridge Investment Research Advisors Inc., Morgan Stanley, Benjamin Edwards, Inc., according to Nexqual as of July 26, 2026 at 22:56 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Cambridge Investment Research Advisors Inc. | 2.67% |
| Morgan Stanley | 1.48% |
| Benjamin Edwards, Inc. | 0.95% |
| Commonwealth Equity Services, LLC | 0.61% |
| LPL Financial LLC | 0.6% |
| Osaic Holdings Inc. | 0.49% |
| Milestone Asset Management, LLC | 0.41% |
| Medallion Wealth Advisors, LLC | 0.24% |
Source: Nexqual, July 26, 2026 at 22:56 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PCM | PCM Fund, Inc. | USD 5.59 | ▼ 0.89% |
| PFL | PIMCO Income Strategy Fund Shar | USD 7.67 | ▼ 0.78% |
| PGP | Pimco Global Stocksplus & Incom | USD 8.34 | ▼ 2% |
| PFN | PIMCO Income Strategy Fund II | USD 7.05 | ▼ 0.14% |
| TEI | Templeton Emerging Markets Inco | USD 6.57 | ▼ 2.52% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 22:56 UTC. This page is informational and not investment advice.